LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Berkshire Hathaway to buy Occidental’s OxyChem for $9.7 billion, in Buffett’s biggest deal in three years

Garry Wills by Garry Wills
October 2, 2025
in Business Finance
Berkshire Hathaway to buy Occidental’s OxyChem for .7 billion, in Buffett’s biggest deal in three years
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

[ad_1]

Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025.

CNBC

Warren Buffett’s Berkshire Hathaway announced Thursday it reached a deal to buy Occidental Petroleum’s petrochemical unit, OxyChem, for $9.7 billion in cash.

The deal marks Berkshire’s largest since 2022, when it paid $11.6 billion for insurer Alleghany. It also comes at a time in which the conglomerate is sitting on $344 billion in cash, near a record for the company.

Shares of Occidental rose 1.4% in premarket trading Thursday following the announcement.

Berkshire is already a major investor in Occidental, holding a 28.2% stake as of the end of June. Buffett — who is 95 and stepping down as CEO at the end of the year — has said he wouldn’t take complete control of the Houston-based oil company.

OxyChem manufactures water treatment, healthcare and other commercial chemicals. Occidental said it will use $6.5 billion of the proceeds to pay down debt.

Occidental CEO Vicki Hollub said the debt reduction resulting from the deal will enable her company to restart buying back stock.

“The problem has been getting our debt down faster, so this resolves the one outstanding issue that I think will now unlock our stock and allow shareholders to feel more comfortable, hopefully, to add to their positions and others to come in,” Hollub said on CNBC’s “Squawk Box” Thursday. “So now we’re going to be able to start our our sharing purchase program again….This is the last step that we needed in our major transformation that we started 10 years ago.”

The last time Berkshire did a deal in the chemical space was in 2011, buying Lubrizol for a similar $10 billion figure.

“We look forward to welcoming OxyChem as an operating subsidiary within Berkshire,” said Greg Abel, Vice Chairman of Non-Insurance Operations at Berkshire, in a press release.

Abel, who will replace Buffett as CEO of Berkshire in 2026, added that Hollub is showing her “commitment to Occidental’s long-term financial stability, as demonstrated by their plan to use proceeds to reinforce the company’s balance sheet.”

Both companies expect the deal to close in the fourth quarter. The Wall Street Journal first reported on the transaction earlier this week.

Buffett first got involved with Occidental in 2019 when he helped bankroll Occidental’s purchase of Anadarko Petroleum with a $10 billion commitment. He received preferred shares and warrants to buy common stock in return. 

Hollub said as Occidental grows its cash position, it will start redeeming Berkshire’s preferred stock in 2029. Occidental currently pays a 8% dividend on Berkshire’s preferreds.

[ad_2]

Source link

You might also like

China exports growth in March misses estimates, imports surge most in over four years

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

Share30Tweet19
Previous Post

JPMorgan’s top picks for October include Amazon and this online car retailer

Next Post

OpenAI hits $500B valuation, surpassing SpaceX as world’s largest startup

Garry Wills

Garry Wills

Recommended For You

China exports growth in March misses estimates, imports surge most in over four years
Business Finance

China exports growth in March misses estimates, imports surge most in over four years

April 14, 2026
Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more
Business Finance

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

April 13, 2026
Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects
Business Finance

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

April 13, 2026
Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions
Business Finance

Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions

April 12, 2026
Next Post
OpenAI hits 0B valuation, surpassing SpaceX as world’s largest startup

OpenAI hits $500B valuation, surpassing SpaceX as world’s largest startup

Related News

As retirement looms, many Gen Xers are still playing catch-up

As retirement looms, many Gen Xers are still playing catch-up

June 20, 2024
Plug Power’s stock rises as it projects big revenue jump by 2027

Plug Power’s stock rises as it projects big revenue jump by 2027

October 11, 2023
The era of listings and on-ramps is ending, as intent protocols make access native

The era of listings and on-ramps is ending, as intent protocols make access native

March 19, 2026

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?